Article
Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
Minerva endocrinologica - 1 Dec 2009
Mirzaei K, Hossein-Nezhad A, Javad Hosseinzadeh-Attar M, Jafari N, Najmafshar A, Mohammadzadeh N, Larijani B
Abstract excerpt
AIM: We investigated the role of the -4689G/T promoter variant of the visfatin gene on serum visfatin concentration and biochemical markers in T2DM patient. METHODS: In a cross-sectional study we recruited 93 patients with type 2 diabetes. Laboratory and anthropometric measurements were included FBG, OGTT, HbA1C, lipid Profile, fasting serum visfatin, fasting serum insulin, weight, height, Body Mass Index (BMI)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
